SCHEMBL5348463

SCHEMBL5348463

O=C(O)CC/C(CCc1ccccc1)=N\O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.64
FFAR1 O14842 12/20 0.60
HDAC2 Q92769 2/20 0.55
HDAC8 Q9BY41 2/20 0.55
HDAC6 Q9UBN7 2/20 0.55
HDAC3 O15379 1/20 0.55
MAPK1 P28482 1/20 0.55
ADRA1A P35348 1/20 0.55
HDAC4 P56524 1/20 0.55
SLC6A3 Q01959 1/20 0.55
HDAC1 Q13547 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
HDAC7 Q8WUI4 1/20 0.55
HDAC10 Q969S8 1/20 0.55
HDAC11 Q96DB2 1/20 0.55
HDAC9 Q9UKV0 1/20 0.55
HDAC5 Q9UQL6 1/20 0.55
MAPT P10636 1/20 0.52
RXFP1 Q9HBX9 1/20 0.52
ALDH1A1 P00352 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5348465 1.00 KEAP1 (0.64) KEAP1FFAR1HDAC2HDAC8HDAC6
SCHEMBL14423596 1.00 KEAP1 (0.64) KEAP1FFAR1HDAC2HDAC8HDAC6
SCHEMBL7280063 0.88 KEAP1 (0.54) KEAP1FFAR1HDAC2HDAC8HDAC6
Phenyl Propionic Acid SCHEMBL27523271 0.80 KEAP1 (1.00) KEAP1FFAR1HDAC2HDAC8HDAC6
Phenyl Propionic Acid SCHEMBL29619843 0.80 KEAP1 (1.00) KEAP1FFAR1HDAC2HDAC8HDAC6
Phenyl Propionic Acid SCHEMBL3419 0.80 KEAP1 (1.00) KEAP1FFAR1HDAC2HDAC8HDAC6
Phenyl Propionic Acid SCHEMBL13618844 0.80 KEAP1 (1.00) KEAP1FFAR1HDAC2HDAC8HDAC6
Phenyl Propionic Acid SCHEMBL235064 0.80 KEAP1 (1.00) KEAP1FFAR1HDAC2HDAC8HDAC6
Phenyl Propionic Acid SCHEMBL6420576 0.79 KEAP1 (0.79) KEAP1FFAR1HDAC2HDAC8HDAC6
SCHEMBL11435918 0.79 KEAP1 (0.48) KEAP1FFAR1HDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7253194-B2 Compounds and inhibitors of phospholipases THE UNIVERSITY OF QUEENSLAND (AU) 2007-08-07 US disclosed
US-7253194-B2 Compounds and inhibitors of phospholipases THE UNIVERSITY OF QUEENSLAND (AU) 2007-08-07 US disclosed
EP-1309552-A4 COMPOUNDS AND INHIBITORS OF PHOSPHOLIPASES UNIV QUEENSLAND (AU) 2005-07-20 EP disclosed
US-20040033995-A1 Compounds and inhibitors of phospholipases QUEENSLAND, THE UNIVERSITY OF (AU) 2004-02-19 US disclosed
EP-1309552-A1 COMPOUNDS AND INHIBITORS OF PHOSPHOLIPASES THE UNIVERSITY OF QUEENSLAND (AU) 2003-05-14 EP disclosed
WO-2002008189-A1 COMPOUNDS AND INHIBITORS OF PHOSPHOLIPASES THE UNIVERSITY OF QUEENSLAND (AU) 2002-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040033995-A1 Compounds and inhibitors of phospholipases PLA2G4C, PLA2G4B, PLA2G4A KEAP1 3037/4885FFAR1 505/4885HDAC2 3326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.